EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+32.06%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$338M
AUM Growth
+$338M
(+87%)
Cap. Flow
+$116M
Cap. Flow
% of AUM
34.33%
Top 10 Holdings %
Top 10 Hldgs %
66.54%
Holding
70
New
15
Increased
24
Reduced
6
Closed
19
Top Buys
| 1 |
NUVA
NuVasive, Inc.
NUVA
|
$18.8M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$16.5M |
| 3 |
Danaher
DHR
|
$14.7M |
| 4 |
eHealth
EHTH
|
$12.5M |
| 5 |
GSK
GSK
|
$11.6M |
Top Sells
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$5.61M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$3.74M |
| 3 |
Merck
MRK
|
$3.53M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$2.67M |
| 5 |
Abbott
ABT
|
$2.27M |
Sector Composition
| 1 | Healthcare | 80.21% |
| 2 | Industrials | 8.48% |
| 3 | Financials | 3.7% |
| 4 | Real Estate | 0.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
1
Amarin Corp
AMRN
$311M
| $42.8M | 12.48% | 2,060,287 +796,880 | +63% | +$16.5M |
|
|
2
GSK
GSK
$79.9B
| $34.1M | 9.94% | 803,185 +273,701 | +52% | +$11.6M |
|
|
RCM
3
DELISTED
R1 RCM Inc. Common Stock
RCM
| $28.7M | 8.36% | 2,963,659 +614,353 | +26% | +$5.94M |
|
|
ZGNX
4
DELISTED
Zogenix, Inc.
ZGNX
| $27.3M | 7.95% | 495,429 -68,000 | -12% | -$3.74M |
|
|
5
Danaher
DHR
$147B
| $21M | 6.12% | 158,764 +110,960 | +232% | +$14.7M |
|
|
NUVA
6
DELISTED
NuVasive, Inc.
NUVA
| $18.8M | 5.48% | +330,601 | New | +$18.8M |
|
7
Sanofi
SNY
$121B
| $14.7M | 4.29% | 332,402 +26,160 | +9% | +$1.16M |
|
|
RDUS
8
DELISTED
Radius Health, Inc.
RDUS
| $12.9M | 3.75% | 645,417 +93,364 | +17% | +$1.86M |
|
|
9
eHealth
EHTH
$118M
| $12.5M | 3.65% | +200,649 | New | +$12.5M |
|
10
Ascendis Pharma
ASND
$11.8B
| $12.2M | 3.55% | 103,296 +88,042 | +577% | +$10.4M |
|
11
Sarepta Therapeutics
SRPT
$1.78B
| $9.96M | 2.91% | 83,574 +43,080 | +106% | +$5.13M |
|
12
The Ensign Group
ENSG
$9.91B
| $8.17M | 2.38% | 159,545 +73,970 | +86% | +$3.79M |
|
|
ABMD
13
DELISTED
Abiomed Inc
ABMD
| $7.81M | 2.28% | 27,339 +13,400 | +96% | +$3.83M |
|
14
Vertex Pharmaceuticals
VRTX
$100B
| $7.03M | 2.05% | 38,229 +1,737 | +5% | +$320K |
|
15
Fate Therapeutics
FATE
$120M
| $6.15M | 1.79% | 350,011 +185,011 | +112% | +$3.25M |
|
16
TG Therapeutics
TGTX
$4.65B
| $6.02M | 1.76% | 748,594 +683,594 | +1,052% | +$5.5M |
|
|
DCPH
17
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $5.81M | 1.7% | 250,432 +180,732 | +259% | +$4.19M |
|
|
AERI
18
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $5.45M | 1.59% | 114,779 -118,011 | -51% | -$5.61M |
|
|
ARRY
19
DELISTED
Array Biopharma Inc
ARRY
| $5.22M | 1.52% | 214,112 +123,700 | +137% | +$3.02M |
|
20
argenx
ARGX
$43.6B
| $4.91M | 1.43% | 39,334 +1,110 | +3% | +$139K |
|
21
PTC Therapeutics
PTCT
$3.92B
| $3.79M | 1.1% | +100,600 | New | +$3.79M |
|
|
ARNA
22
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $3.39M | 0.99% | 75,721 -5,650 | -7% | -$253K |
|
23
BioCryst Pharmaceuticals
BCRX
$1.74B
| $3.36M | 0.98% | 412,876 +248,917 | +152% | +$2.03M |
|
|
ARQL
24
DELISTED
Arqule Inc
ARQL
| $3.1M | 0.9% | 646,918 +302,300 | +88% | +$1.45M |
|
|
TLGT
25
DELISTED
Teligent, Inc
TLGT
| $2.99M | 0.87% | 2,574,883 +327,407 | +15% | +$380K |
|